Form 4 Tracker
CORCEPT THERAPEUTICS INC
CORT

84 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 7, 2026Apr 7 4:08 PMGuyer William
Proposed Sale
20,000$40.85$817.0K—

View →

Mar 25, 2026Mar 27 8:27 PMBELANOFF JOSEPH KDirector, Chief Executive Officer
Sale
26,198$50.07$1.3M2,918,326(I)

View →

Mar 25, 2026Mar 25 7:49 PMBELANOFF JOSEPH K
Proposed Sale
40,000$33.82$1.4M—

View →

Mar 20, 2026Mar 24 8:54 PMWilliam GuyerChief Development Officer
Sale
11,767$36.01$423.7K2,231(D)

View →

Mar 17, 2026Mar 19 9:07 PMBAKER G LEONARD JRDirector
Purchase
100,000$33.14$3.3M1,146,631(D)

View →

Mar 4, 2026Mar 6 9:30 PMWilliam GuyerChief Development Officer
Sale
8,233$35.99$296.3K2,231(D)

View →

Mar 4, 2026Mar 4 9:02 PMGuyer William
Proposed Sale
20,000$35.28$705.6K—

View →

Feb 3, 2026Feb 5 10:42 PMWilliam GuyerChief Development Officer
Sale
20,000$40.87$817.3K1,235(D)

View →

Feb 3, 2026Feb 3 4:26 PMGuyer William
Proposed Sale
20,000$40.71$814.2K—

View →

Jan 6, 2026Jan 6 5:04 PMGuyer William
Proposed Sale
20,000$34.95$699.0K—

View →

Dec 2, 2025Dec 2 3:34 PMGuyer William
Proposed Sale
20,000$79.78$1.6M—

View →

Dec 1, 2025Dec 1 7:36 PMBELANOFF JOSEPH K
Proposed Sale
40,000$79.40$3.2M—

View →

Dec 1, 2025Dec 1 7:00 PMMaduck Sean
Proposed Sale
20,000$79.40$1.6M—

View →

Dec 1, 2025Dec 1 6:50 PMLyon Joseph Douglas
Proposed Sale
5,000$79.40$397.0K—

View →

Nov 25, 2025Nov 25 9:46 PMGuyer William
Proposed Sale
4,500$80.90$364.1K—

View →

Nov 5, 2025Nov 5 3:12 PMGuyer William
Proposed Sale
20,000$71.10$1.4M—

View →

Nov 3, 2025Nov 3 9:06 PMBELANOFF JOSEPH K
Proposed Sale
40,000$73.47$2.9M—

View →

Nov 3, 2025Nov 3 8:31 PMLyon Joseph Douglas
Proposed Sale
5,000$73.47$367.4K—

View →

Nov 3, 2025Nov 3 8:25 PMMaduck Sean
Proposed Sale
20,000$73.47$1.5M—

View →

Oct 10, 2025Oct 10 2:44 PMSwisher Daniel N JR
Proposed Sale
2,200$87.54$192.6K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 1, 2026Jul 6 8:44 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
25,000$8.27116,986(D)

View →

Jun 15, 2026Jun 17 8:30 PMAtabak MokariChief Financial Officer
Option Exercise
40,000$19.2620,000(D)

View →

Jun 2, 2026Jun 4 8:49 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65150,000(D)

View →

Jun 1, 2026Jun 3 11:20 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
25,000$8.27141,986(D)

View →

Jun 1, 2026Jun 3 11:20 PMAtabak MokariChief Financial Officer
Option Exercise
40,000$19.2660,000(D)

View →

May 27, 2026May 29 10:03 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
75,000$8.27166,986(D)

View →

May 21, 2026May 26 9:40 PMBAKER G LEONARD JRDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:39 PMGregg H AltonDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:36 PMJames N WilsonDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:35 PMDaniel N Swisher JRDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:33 PMJoshua M. MurrayDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:31 PMDavid L MahoneyDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:28 PMKimberly ParkDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 5, 2026May 7 8:30 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65170,000(D)

View →

Apr 7, 2026Apr 8 11:34 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65190,000(D)

View →

Mar 20, 2026Mar 24 8:54 PMWilliam GuyerChief Development Officer
Option Exercise
11,767$21.65210,000(D)

View →

Mar 13, 2026Mar 17 11:52 PMDavid L MahoneyDirector
Option Exercise
30,000$5.860(D)

View →

Mar 4, 2026Mar 6 9:30 PMWilliam GuyerChief Development Officer
Option Exercise
8,233$21.65221,767(D)

View →

Feb 27, 2026Mar 3 11:19 PMJoseph Douglas LyonChief Accounting & Technology Officer
Grant/Award
140,000$35.70140,000(D)

View →

Feb 27, 2026Mar 3 11:17 PMBELANOFF JOSEPH KDirector, Chief Executive Officer
Grant/Award
460,000$35.70460,000(D)

View →